INT MEDICAL (01501) has issued an announcement stating that, in order to advance the proposed A-share issuance, improve domestic audit efficiency, and avoid duplicative audit work, the Board has recommended, following review and approval by the Audit Committee of the Board, not to reappoint KPMG Huazhen LLP (Special General Partnership) as the Company's domestic auditor for 2026, and instead proposes to appoint BDO China Shu Lun Pan Certified Public Accountants LLP (Special General Partnership) as the Company's domestic auditor for 2026, responsible for auditing the financial statements prepared in accordance with Chinese Accounting Standards for Business Enterprises.
BDO China Shu Lun Pan has already been engaged by the Company as the special audit institution for the proposed A-share issuance. As the Company's financial statements for the year ending December 31, 2026 will constitute the reporting period for the financial information contained in the filing documents for the proposed A-share issuance, the Board believes that appointing BDO China Shu Lun Pan as the 2026 domestic auditor will avoid duplicative audit work and enhance domestic audit efficiency.
Comments